Delivery Order SPE2DB22D1202-SPE2DB24FVNA6
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $92,821.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of KISQALI 400 MG DAILY DOSE 42S medication. The contract has a firm fixed price of $8,605.98 and an ultimate completion date of May 21, 2025. The award is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,247,998 units of the drug KISQALI 400 MG DAILY DOSE 42S, with a ceiling value of $33,893.30. The contract has a period of performance through May 15, 2025 and is a firm fixed-price type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $57,949.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of KISQALI 400 MG DAILY DOSE 42S, a medication. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a...
This is a $20,396.05 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for KISQALI 600 MG DAILY DOSE 63S, a medication, with a completion date of February 11, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract the company holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corporation for $17,752.54 to provide KISQALI 600 mg daily dose pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure essential medical commodities, including specialty, brand name, generic, and...
This is a $28,447.94 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of 4565733846 - KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,631.72, is for the supply of KISQALI 200 MG DAILY DOSE medication. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,071.18, is for the supply of KISQALI 600 MG DAILY DOSE 63S, a prescription medication. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,281.68 contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication, to support federal healthcare programs. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...